Following a warning by a UK regulator about a small risk of severe acute pancreatitis with weight loss jabs, Medical News Today spoke to 3 experts about who is most at risk and whether the benefits ...

Abhishek Sharma has been hospitalised with a stomach infection, likely acute gastroenteritis, raising doubts over his T20 ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

When we first started this project, I was extremely skeptical,” said Dr. Elisabeth Wilde. “But we’ve seen consistent results across multiple of our studies, so it’s starting to be quite compelling.” ...

Background: The prognostic nutritional index (PNI), reflecting nutritional and immune-inflammatory status, has been linked to outcomes across a range of disorders. Its prognostic value in acute ...

“Inflammation is the cornerstone of Alzheimer's disease and Parkinson's, multiple sclerosis—all of the neurodegenerative diseases are really predicated on inflammation.” –David Perlmutter The immune ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and scarring. Signals from the gut make the situation worse by encouraging immune ...

New research is shedding light on surprising ways to reduce chronic inflammation—including suggestions as simple as flossing your teeth. From infrared saunas to meditation, there are several steps you ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, ...

Inflammation has become somewhat of a wellness buzzword in recent years. It's often used as a scapegoat for a myriad of vague health problems: fatigue, bloating, acne, weight gain, brain fog. The list ...

This illustration depicts the experimental workflow using a mouse model of LPS-induced acute systemic inflammation and PiTMaP-based metabolomics. Metabolic profiles were compared across major brain ...

Close to two years after AbbVie handed over $48 million for the rights to Ose Immunotherapeutics’ inflammation drug, the Big Pharma now wants the French biotech to keep an eye on the asset for a while ...